Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Recruiting · NCT07139743 · Registry updated 2026-03-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Obe-cel in Refractory Progressive Forms of Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Recruiting | Phase 1 | 2026-03-23 | NCT07139743 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Autolus Limited | 7 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Addenbrooke's Hospital | Cambridge | United Kingdom | 26 |
| Hospital Universitari i Politecnic La Fe de Valencia | Valencia | Spain | 3 |
| Hospital Universitario Vall d'Hebron - PPDS | Barcelona | Spain | 1 |
| Royal Hallamshire Hospital | Sheffield | United Kingdom | 9 |
| Stanford University | Redwood City | United States | 25 |
| The National Hospital for Neurology & Neurosurgery | London | United Kingdom | 1 |
| Western General Hospital Edinburgh - PPDSE Edinburgh | Edinburgh | United Kingdom | 1 |